Edwards Lifesciences Corp

DnB Asset Management AS EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

300,237

Value ($000)

25,595

Weight

0.1%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	25,595	0.1%	300,237	12/31/2025
2025 Q3	11/12/2025	23,693	0.1%	304,655	9/30/2025
2025 Q2	8/12/2025	23,290	0.1%	297,794	6/30/2025
2025 Q1	5/15/2025	22,912	0.1%	316,114	3/31/2025
2024 Q4	2/12/2025	24,276	0.1%	327,924	12/31/2024
2024 Q3	11/12/2024	20,891	0.1%	316,576	9/30/2024
2024 Q2	7/5/2024	21,736	0.1%	235,311	6/30/2024
2024 Q1	4/12/2024	18,758	0.1%	196,296	3/31/2024
2023 Q4	1/4/2024	18,536	0.1%	243,091	12/31/2023
2023 Q3	10/13/2023	16,811	0.1%	242,656	9/30/2023
2023 Q2	7/10/2023	20,916	0.1%	221,730	6/30/2023
2023 Q1	4/20/2023	16,740	0.1%	202,351	3/31/2023
2022 Q4	1/12/2023	15,309	0.1%	205,188	12/31/2022
2022 Q3	10/11/2022	14,636	0.1%	177,121	9/30/2022
2022 Q2	7/8/2022	15,022	0.1%	157,972	6/30/2022
2022 Q1	4/8/2022	16,189	0.1%	137,520	3/31/2022
2021 Q4	1/12/2022	20,124	0.1%	155,338	12/31/2021
2021 Q3	10/15/2021	16,899	0.1%	149,268	9/30/2021
2021 Q2	7/6/2021	10,685	0.1%	103,170	6/30/2021
2021 Q1	4/15/2021	12,155	0.1%	145,320	3/31/2021
2020 Q4	1/19/2021	10,268	0.1%	112,554	12/31/2020
2020 Q3	10/14/2020	7,827	0.1%	98,057	9/30/2020
2020 Q2	7/8/2020	5,107	0.1%	73,892	6/30/2020
2020 Q1	4/17/2020	4,215	0.1%	22,349	3/31/2020
2019 Q4	1/13/2020	5,881	0.1%	25,207	12/31/2019
2013 Q4	1/27/2014	1,869	0.0%	28,423	12/31/2013